Browse By: Country ι Category ι Publisher ι Tag

Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues, 2013 Edition

Pages » 208
Published By » JustPharmaReports.com
Price » $2350
In stock
View Report Details
Description

The cost of treating rare disease in an age when austerity measures are hitting total healthcare funding across Europe is a highly controversial, even emotive subject. There is a clear and pressing clinical need, a strong patient voice and the treatments themselves sometimes offer the only hope. But is this enough to assure premium prices and special status in an era of budget limitations, and growing demands for evidence of clinical and cost effectiveness? Payers are becoming increasingly strict. Four of the first seven orphan drugs to enter Germany’s AMNOG procedure were considered to bring only minor additional benefit and for two others the benefit was deemed non-quantifiable....


Orphan Drugs in Europe: Pricing, Reimbursement, Funding & Market Access Issues, 2011 Edition
The cost of treating rare disease in an age when austerity measures are hitting total healthcare funding across Europe is a highly controversial, even emotive subject. There is a clear and pressing clinical need, a strong patient voice and the treatments themselves sometimes offer the only h
Published Date: Jun 2011
Price: $2300
Market Access Korea: Breaking into the Developed World\'s Fastest Growing Pharmaceutical Market
South Korea as a country has been an economic success story and the origin of much cutting edge technology, but its pharmaceutical market can now also be given ‘Asian tiger’ status. The past four years have seen total sales growth of 15.6%, 13.5%, 12.4% and 13.8% respectively. IMS
Published Date: Nov 2010
Price: $1380
Orphan Drugs in Asia-Pacific: From Designation to Pricing, Funding & Market Access
A major new report Orphan Drugs in Asia-Pacific: From designation to pricing, funding and market access focuses on five developed markets in the region: Japan, South Korea, Taiwan, Singapore and Australia. Each has passed specific measures to promote the development, registration and/or commer
Published Date: Feb 2010
Price: $2320
Biosimilars: Current Situation & Future Prospects, Worldwide
The engine of the biosimilar sector is the same as with small molecule drugs, patent expiry. On this basis, prospects for biosimilars look good, with the vast majority of leading originator brands in the global biologics market expected to lose some degree of protection by 2019. All major countr
Published Date: Mar 2012
Price: $3000
Pharmaceutical Pricing & Distribution in Japan, 2010 Update
The author’s 2008 major title ‘Pharmaceutical Pricing & Distribution in Japan’ was described by PhRMA Japan as ‘a superb report…to understand Japan there is nothing better’. His new report packs all the essentials needed to optimise market access and life
Published Date: Oct 2011
Price: $760
Pharmaceutical Pricing & Distribution in Japan, 2012 Update
No serious pharmaceutical company can afford to ignore Japan, a $120 billion market, the second-largest in the world. It remains a tough and highly competitive market to crack, however, with the environment for developing and marketing medicines dominated by price.  No new bran
Published Date: Jun 2012
Price: $1400
Risk Sharing and Other Forms of Managed Entry Agreements for Medicines, Worldwide
Managed entry agreements apply to an increasing number of new, innovative drugs in a growing number of markets. They are designed to share the risk between the manufacturer and the payer, consequent on uncertainties - usually at launch - about the product’s value (clinical- and cost-effect
Published Date: Feb 2013
Price: $1050
Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues, 2013 Edition
The cost of treating rare disease in an age when austerity measures are hitting total healthcare funding across Europe is a highly controversial, even emotive subject. There is a clear and pressing clinical need, a strong patient voice and the treatments themselves sometimes offer the only hope. B
Published Date: Oct 2013
Price: $2350

 


 

Related News

Germany Trims Non-Renewable Energy Sector, Companies Worry about Growth
Many of Germany’s companies, investors, economists, and neighboring countries are worried about Germany’s move to introduce a large-scale renewable energy program. The country faces enormous costs to replace a system that was already in effect and working, with a project to start utilizing cleaner energy sources. In their effort to gradually wean off nuclear and fossil fuel energy, Germany’s Energiewende plans to spend a trillion Euros to do so. The North Sea wind farm Bard
Date: Aug 27

GM Faulty Ignition-switch Program Registers More than 100 Death Claims
The General Motors’ program built to compensate victims of crashes caused due to faulty ignition switches in company’s vehicles has received 107 claims for death as of Tuesday, according to Amy Weiss, the spokesperson for Kenneth Feinberg - the lawyer handling the program.  Amy stated that the 107 death claims are amongst the 309 claims submitted in the program so far. The program started to accept claims on the 1st August, and will continue till 31st December.  For a
Date: Aug 27

BOC Aviation Places Order For Boeing Planes Worth a Record Amount
The leasing subsidiary of Bank of China, BOC Aviation has recently placed the biggest order of planes in its 20-year history. The order, which is reportedly worth $8.8 billion, comprises of two long-haul wide-body planes of the 777-300ER series, 30 Next Generation aircrafts of the 737-800 series, 50 Boeing planes of the 737 Max 8 series. The order comes only a week after the China-based leasing body SMBC Aviation had placed orders for 115 Airbus jet planes.  The huge financing of leasin
Date: Aug 26

Japan to Seek Over ¥5 Trillion Defense Budget
In what is a record-high budget request, the defense ministry of Japan plans to request more than 5 trillion yen in the fiscal year 2015 beginning next April. A formal announcement will be made next Friday and includes high priority costs that are in line with Prime Minister Shinzo Abe’s new strategies on defense and security.  The budget sought after is 3.5% higher than this fiscal year’s request and includes defense of the remote islands of Japan, creation of an amphibious
Date: Aug 25

India to Global Auto Hub by 2020
Global automobile manufacturers are eyeing India as a lucrative option to set up businesses. This shift in perception is due to country’s growing domestic market and its growth potential. The automakers will also focus on exports from India. Report published by Standard Chartered Bank states, for global operations Hyundai will source its engines from India; Ford will manufacture engines in India for its Asia-Pacific and Africa region; and Volkswagen will increase its sourcing from India
Date: Aug 25

New Transparent Material can Work as a Solar Power Generator
A team of scientists at Michigan State University declared this week the creation of a luminescent transparent solar concentrator which has the potential to turn windows and cell phone screens into solar-power generating equipment. This technology can revolutionize the way we use solar power. It cans enable entire skyscrapers one day to generate solar power without obstructing light or the view. This new material works by absorbing light from the invisible spectrum which is ultraviolet and ne
Date: Aug 25

Brits Picks U.S. Companies for Defense Contracts
Bechtel and CH2M Hill, both U.S.-based firms, have been chosen by Britain to operate sections of its military equipment buying program. The British Ministry of Defense (MOD) has made the move in an effort to restructure its equipment purchasing programs for the armed forces, by trying to utilize public spending. This reportedly involves renovating the Defense Equipment & Support (DE&S) segment. The DE&S has been criticized for multiple delays and budget overruns. The MOD plans to
Date: Aug 21

Indian Telecom Authority Scraps Telecom Players Plea to Charge Messaging Apps
Earlier in August 2014, leading Indian telecom market participants had united to lodge an appeal with the Telecom Regulatory Authority of India (TRAI) to levy a connectivity fee on customers that were using messaging and VOIP apps such as Viber, WeChat, and WhatsApp. A string of meetings ensued between the government agency and private players, as the latter claimed they were losing about INR 5000 crore per year to consumers installing apps from Over The Top Players and bypassing core services (
Date: Aug 21

Skinny Jeans Trend is Over, says Fashion Industry
To snuff out the trend of skinny jeans, clothing merchants tried to introduce new innovation called flares. However, women went on buying skinny jeans. Currently, mass marketing chains such as Gap Inc. and Bloomingdale’s luxury chain are trying again to snuff out the trend of skinny jeans with looser styles. Gap has introduced dressy sweat pants. The goal of these chains is to get women consumers to buy new wardrobes and jolt out anemic apparel sales. According to a chief industry analy
Date: Aug 21

Downfall in Profits Drops Mincon Stocks
Mincon - Clare-based mining equipment company’s share fell as its short-term results disappointed investors all around the world yesterday. The company is paying €7m for a 65pc stake in a Canadian firm and nearly €1m in two other businesses. Mincon exhibited a fall in its revenue of 15pc to €23.4m in the first six months of the year. Its operating profit slumped 37pc to €5.1m. As compared to its direct sales which were at €18.9m (7pc lower), the third-party product
Date: Aug 21

Upcoming Reports

Antiemetic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Antiemetics are therapeutic agents which are used to treat vomiting and nausea caused by several medical conditions. Nausea and vomiting are not diseases, they are symptoms associated with a variety of medical conditions such as gastroenteritis, motion sickness, dizziness, pregnancy, overeating, emo
Published By: Transparency Market Research
Price: $4795
Alzheimers Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018
Alzheimer’s disease is a neurological disorder of the brain which is progressive and ultimately leads to loss of neurons. This condition leads to loss of memory and reasoning abilities. Currently, there is no treatment for Alzheimer’s, although there are certain ways of slowing down it
Published By: Transparency Market Research
Price: $4795
Acute Myeloid Leukemia (AML) Therapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
Acute myeloid leukemia grows at a fast pace and is found in the blood and bone marrow. The leukemia therapeutics market is divided into four segments namely acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myeloid leukemia. In the disease process, imma
Published By: Transparency Market Research
Price: $4795
Antibiotic Market - Global Industry Size, Share, Trends, Analysis And Forecast, 2012 - 2018
An antibiotic is a compound or a substance that fights bacterial infections and kills or slow down their growth. The antibiotic market is witnessing high growth due new product innovations and higher investment in R & D activity. Moreover, the other regulatory concerns to control the antibioti
Published By: Transparency Market Research
Price: $4795
Next Generation Sequencers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Next generation sequencers are used inthe sequencing technologies which massively parallelize the DNA sequencing process rather than being limited to single or few fragments of DNA. The next generation sequencing (NGS) technology enables rapid sequencing and produce thousands and millions of seque
Published By: Transparency Market Research
Price: $4795
Rheumatoid Arthritis Pharmacotherapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal
Published By: Transparency Market Research
Price: $4795
Prenatal Diagnostics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Prenatal diagnostics is a procedure for testing of diseases before the birth of a child, to determine certain inheritable disorders such as chromosome abnormalities, Down’s syndrome, genetic diseases, neural tube defects, and other conditions. It can be conducted by various procedures of scr
Published By: Transparency Market Research
Price: $4795
Pediatric Vaccines Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global pediatric vaccine market is forecasted to reach $24.3 billion by the year 2017 at a compounded annual growth rate of 11.5 % during 2011-2017. This growth in revenues is expected to be driven by the introduction of new molecules that are currently in regulatory filing stage and those i
Published By: Transparency Market Research
Price: $4795
Dermatological Diagnostics And Therapeutics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The Dermatological diagnostics and therapeutics market is expected to grow steadily during the forecast period driven by increase in psoriasis market that is expected to boost competition among the existing products with more emerging therapies. Acne is the largest market segment of the dermatolog
Published By: Transparency Market Research
Price: $4795
Hepatitis C Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The world market for HCV drugs represents an area of potential opportunities in developed as well as developing countries. Because of the technological advancements and effectiveness, many big market players are focusing on development of innovative drugs for HCV. Major companies are forming coali
Published By: Transparency Market Research
Price: $4795